Home
SGS Quay Pharma

SGS Quay Pharma Market Share Analysis for June 2026

We are the world's leading Testing, Inspection and Certification company.

Industry: N/A

Domainsgsquaypharma.com

Year Founded2002

Employees51 - 200

Annual Revenue--

SGS Quay Pharma

SGS Quay Pharma (including company regionals)

sgsquaypharma.com

See more website traffic and engagement information

Total visits to SGS Quay Pharma's top domains

Understand SGS Quay Pharma market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in SGS Quay Pharma's top domains

Analyze SGS Quay Pharma engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on SGS Quay Pharma's top domains

See how SGS Quay Pharma keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

SGS Quay Pharma top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by SGS Quay Pharma

These are the website technologies, by industry, used by SGS Quay Pharma top domains

Widget (3)

Twemoji

Audio Video Media (1)

Vimeo

Content Management System (1)

WordPress

Conversion & Analytics (1)

Google Analytics

More Technologies

4

See all

News & Signals from SGS Quay Pharma

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsQuaypharma receives award Award for Enterprise.SGS's Quay Pharma, a leading pharmaceutical contract development and manufacturing organization (CDMO), has received the Queen's Award for Enterprise.

NewsQuaypharma is developing LIV001.SGS Quay Pharma partners with Liveome to develop & commercialize LIV001.

NewsLiveome partners with Quaypharma.Liveome, a subsidiary of Medytox, has signed contract development and manufacturing organization (CDMO) contracts with Australia’s Luina Bio and U.K.’s Quay Pharma to develop an inflammatory bowel disease candidate, LIV001.